HIF1A and infection: Taken together, these data identify (to our knowledge) a novel function of α-ketoglutarate–sensing platforms, including those responsible for HIF-1α stabilization, in the resolution of SARS-CoV-2 infection and support targeting these metabolic nodes as a viable therapeutic strategy to limit disease severity during infection.